Skip to Content

WPI 2234 (Tetracycline Hydrochloride 250 mg)

Pill with imprint WPI 2234 is Orange & Yellow, Capsule-shape and has been identified as Tetracycline Hydrochloride 250 mg. It is supplied by Watson Pharmaceuticals, Inc..

Tetracycline is used in the treatment of bacterial infection; acne; bladder infection; bronchitis; nongonococcal urethritis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2234

Tetracycline hydrochloride 250 mg WPI 2234

Tetracycline Hydrochloride

Imprint
WPI 2234
Strength
250 mg
Color
Orange & Yellow
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2234
Inactive Ingredients
lactose, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, gelatin, titanium dioxide, benzyl alcohol, butylparaben, D&C Red No. 22, edetate calcium disodium, methylparaben, propylparaben, silicon dioxide, sodium propionate, shellac, ferrosoferric oxide, dimethicone, water, ethylene glycol monoethyl ether, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, soya lecithin, butyl alcohol, alcohol, aluminum oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.